Liz Parrish discusses gene therapy at the HackMyAge podcast by Zora, March 2021
The document is long but well-annotated. The most important part of this document is the human data that will be released in May or early June for certain treatments. They had a study on mice where they were expecting a paper to be out by now, but other groups helped with additional testing. So there’s a delay.
Zora Benhamou, host of the new podcast \”HackMyAge\”, interviews Liz Parrish CEO of BioViva Sciences and patient 0 of biological rejuvenation using gene therapies.
Liz delves into gene therapy during the discussion, whether it is to cure monogenic diseases, multifactorial genetic diseases or even the mother of diseases: aging.
There is no waste in the conversation lasting one hour and 20 minutes. To focus on a specific topic, use the following time markers:
Zora introduces Liz Parrish, and the topic of the conversation.
Liz Parrish starts her podcast intervention at 0:02;17.
0:03 – What is genetherapy and how Liz became involved with gene therapy for aging?
How Liz and son deal with type 1 diabetes.
How Liz became the first person to be treated with genetherapy to treat biological ageing and what it meant to undergo gene therapy.
0:14.34 The current legal status of gene therapy and how to obtain the treatment.
0:16.20 Costs of gene therapy today.
0:18.49 Why don’t doctors use gene therapies more often than they do? What is the role of medical travel?
0:21.34 What motivated Liz to be the first patient to receive gene therapy to treat biological aging?
How do gene therapies compare to nutraceuticals or pharmaceuticals?
Why the big pharmaceutical companies aren’t more aggressive in this field.
How long before gene therapies become mainstream?
How gene therapy works and what the patient experiences.
0:48.11 What is to be expected when treating sarcopenia using gene therapy?
0:50.02 From where do the genes for gene therapy come?
What can someone expect who has been treated with genetherapy to combat dementia?
What major changes have Liz’s blood markers experienced since she was treated?
When and how Liz went through her gene therapy, not only with hTERT or Follistatin, but also Klotho or PGC-1alpha? What is the purpose of these two?
Liz’s vision of the future.
Liz gives her comments about a forthcoming paper BioViva will be working with Rutgers University.
Other studies are in the pipeline.
BioViva explains its testing services and data-storage options at 1:06:45.
Liz discusses topical creams or small molecules to remove senescent cell and pills that lengthen telomeres.
Liz replies to \”If you could meet yourself at 20, what would you say?\”
What can you do to support Liz in her mission?
Learn more about genomics and gene technology.
Websites of BioViva, Integrated Health Systems and social media sites that Liz and BioViva actively participate in.
1:25.38 Farewell words
Websites:
HackMyAge: https://hackmyage.com/
BioViva Science: https://bioviva-science.com/
Integrated Health Systems: https://www.integrated-health-systems.com/
Source:
